YAMA'S LEA'S SHIELD FEMALE BARRIER CONTRACEPTIVE NEEDS 200-PATIENT STUDY, FDA PANEL FINDS; EXISTING DATA INSUFFICIENT TO ESTABLISH PREGNANCY RATE